(3,4-Dihydroxyphenyl)[2,4,6-trihydroxy-3-[2,3,6-tris-O-(3,4,5-trihydroxybenzoyl)-I(2)-D-glucopyranosyl]phenyl]methanone

Details

Top
Internal ID 134e4dcb-e9a7-4d07-8aa0-e0ec5a5f0626
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Glycosyl compounds > Phenolic glycosides
IUPAC Name [(2R,3R,4S,5S,6S)-6-[3-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxyphenyl]-3-hydroxy-4,5-bis[(3,4,5-trihydroxybenzoyl)oxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
SMILES (Canonical) C1=CC(=C(C=C1C(=O)C2=C(C=C(C(=C2O)C3C(C(C(C(O3)COC(=O)C4=CC(=C(C(=C4)O)O)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)OC(=O)C6=CC(=C(C(=C6)O)O)O)O)O)O)O
SMILES (Isomeric) C1=CC(=C(C=C1C(=O)C2=C(C=C(C(=C2O)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COC(=O)C4=CC(=C(C(=C4)O)O)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)OC(=O)C6=CC(=C(C(=C6)O)O)O)O)O)O)O
InChI InChI=1S/C40H32O23/c41-16-2-1-12(3-17(16)42)29(51)27-18(43)10-19(44)28(34(27)56)35-37(63-40(59)15-8-24(49)32(54)25(50)9-15)36(62-39(58)14-6-22(47)31(53)23(48)7-14)33(55)26(61-35)11-60-38(57)13-4-20(45)30(52)21(46)5-13/h1-10,26,33,35-37,41-50,52-56H,11H2/t26-,33-,35+,36+,37+/m1/s1
InChI Key KBVKYXGJABWIOL-AITSTBGFSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C40H32O23
Molecular Weight 880.70 g/mol
Exact Mass 880.13343726 g/mol
Topological Polar Surface Area (TPSA) 409.00 Ų
XlogP 2.50
Atomic LogP (AlogP) 1.91
H-Bond Acceptor 23
H-Bond Donor 15
Rotatable Bonds 10

Synonyms

Top
3-(2-O,3-O,6-O-Trigalloyl-beta-D-glucopyranosyl)-2,3',4,4',6-pentahydroxybenzophenone
(3,4-Dihydroxyphenyl)[2,4,6-trihydroxy-3-[2,3,6-tris-O-(3,4,5-trihydroxybenzoyl)-beta-D-glucopyranosyl]phenyl]methanone
92631-86-2

2D Structure

Top
2D Structure of (3,4-Dihydroxyphenyl)[2,4,6-trihydroxy-3-[2,3,6-tris-O-(3,4,5-trihydroxybenzoyl)-I(2)-D-glucopyranosyl]phenyl]methanone

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.5186 51.86%
Caco-2 - 0.8911 89.11%
Blood Brain Barrier - 0.7000 70.00%
Human oral bioavailability - 0.6286 62.86%
Subcellular localzation Mitochondria 0.7330 73.30%
OATP2B1 inhibitior - 0.7025 70.25%
OATP1B1 inhibitior + 0.6971 69.71%
OATP1B3 inhibitior - 0.4328 43.28%
MATE1 inhibitior - 0.8000 80.00%
OCT2 inhibitior - 0.5000 50.00%
BSEP inhibitior + 0.8954 89.54%
P-glycoprotein inhibitior + 0.7410 74.10%
P-glycoprotein substrate - 0.7596 75.96%
CYP3A4 substrate + 0.6004 60.04%
CYP2C9 substrate - 0.8118 81.18%
CYP2D6 substrate - 0.8520 85.20%
CYP3A4 inhibition - 0.9212 92.12%
CYP2C9 inhibition - 0.8573 85.73%
CYP2C19 inhibition - 0.9189 91.89%
CYP2D6 inhibition - 0.9675 96.75%
CYP1A2 inhibition - 0.9396 93.96%
CYP2C8 inhibition + 0.7857 78.57%
CYP inhibitory promiscuity - 0.8028 80.28%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9400 94.00%
Carcinogenicity (trinary) Non-required 0.7437 74.37%
Eye corrosion - 0.9929 99.29%
Eye irritation - 0.8792 87.92%
Skin irritation - 0.8385 83.85%
Skin corrosion - 0.9610 96.10%
Ames mutagenesis + 0.5800 58.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7379 73.79%
Micronuclear + 0.7266 72.66%
Hepatotoxicity - 0.6125 61.25%
skin sensitisation - 0.8785 87.85%
Respiratory toxicity + 0.6444 64.44%
Reproductive toxicity + 0.5778 57.78%
Mitochondrial toxicity + 0.5375 53.75%
Nephrotoxicity - 0.9415 94.15%
Acute Oral Toxicity (c) III 0.6972 69.72%
Estrogen receptor binding + 0.7317 73.17%
Androgen receptor binding + 0.7556 75.56%
Thyroid receptor binding - 0.4905 49.05%
Glucocorticoid receptor binding - 0.5000 50.00%
Aromatase binding - 0.5785 57.85%
PPAR gamma + 0.6804 68.04%
Honey bee toxicity - 0.8586 85.86%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity - 0.5400 54.00%
Fish aquatic toxicity + 0.9287 92.87%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.29% 91.11%
CHEMBL1951 P21397 Monoamine oxidase A 98.39% 91.49%
CHEMBL3475 P05121 Plasminogen activator inhibitor-1 96.01% 83.00%
CHEMBL226 P30542 Adenosine A1 receptor 93.61% 95.93%
CHEMBL3194 P02766 Transthyretin 92.93% 90.71%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 90.60% 96.09%
CHEMBL1293249 Q13887 Kruppel-like factor 5 90.57% 86.33%
CHEMBL3401 O75469 Pregnane X receptor 90.35% 94.73%
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 90.23% 95.17%
CHEMBL3060 Q9Y345 Glycine transporter 2 87.73% 99.17%
CHEMBL4208 P20618 Proteasome component C5 87.17% 90.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 85.96% 89.00%
CHEMBL3864 Q06124 Protein-tyrosine phosphatase 2C 82.27% 94.42%
CHEMBL3891 P07384 Calpain 1 81.39% 93.04%
CHEMBL3137262 O60341 LSD1/CoREST complex 80.63% 97.09%

Cross-Links

Top
PubChem 101352486
NPASS NPC165266
LOTUS LTS0098862
wikiData Q105138548